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Abstract
Background  and  objectives:  In  children  undergoing  congenital  heart  surgery,  plasma  brain  natri-
uretic peptide  levels  may  have  a  role  in  development  of  low  cardiac  output  syndrome  that  is
deﬁned  as  a  combination  of  clinical  ﬁndings  and  interventions  to  augment  cardiac  output  in
children  with  pulmonary  hypertension.
Methods:  In  a  prospective  observational  study,  ﬁfty-one  children  undergoing  congenital  heart
surgery  with  preoperative  echocardiographic  study  showing  pulmonary  hypertension  were
enrolled.  The  plasma  brain  natriuretic  peptide  levels  were  collected  before  operation,  12,
24  and  48  h  after  operation.  The  patients  enrolled  into  the  study  were  divided  into  two  groups
depending  on:  (1)  Development  of  LCOS  which  is  deﬁned  as  a  combination  of  clinical  ﬁndings
or  interventions  to  augment  cardiac  output  postoperatively;  (2)  Determination  of  preoperative
brain  natriuretic  peptide  cut-off  value  by  receiver  operating  curve  analysis  for  low  cardiac  out-
put  syndrome.  The  secondary  end  points  were:  (1)  duration  of  mechanical  ventilation  ≥72  h,
(2)  intensive  care  unit  stay  >7days,  and  (3)  mortality.
Results:  The  differences  in  preoperative  and  postoperative  brain  natriuretic  peptide  levels
of patients  with  or  without  low  cardiac  output  syndrome  (n  =  35,  n  =  16,  respectively)  showed
signiﬁcant  differences  in  repeated  measurement  time  points  (p  =  0.0001).  The  preoperative
−1brain natriuretic  peptide  cut-off  value  of  125.5  pg  mL was  found  to  have  the  highest  sensitivity
of  88.9%  and  speciﬁcity  of  96.9%  in  predicting  low  cardiac  output  syndrome  in  patients  with
pulmonary  hypertension.  A  good  correlation  was  found  between  preoperative  plasma  brain
natriuretic  peptide  level  and  duration  of  mechanical  ventilation  (r  =  0.67,  p  =  0.0001).
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Conclusions:  In  patients  with  pulmonary  hypertension  undergoing  congenital  heart  surgery,  91%
of  patients  with  preoperative  plasma  brain  natriuretic  peptide  levels  above  125.5  pg  mL−1 are  at
risk  of  developing  low  cardiac  output  syndrome  which  is  an  important  postoperative  outcome.
©  2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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O  valor  preditivo  do  peptídeo  natriurético  tipo-B  em  resultados  de  crianc¸as  com
hipertensão  pulmonar  submetidas  à  cirurgia  cardíaca  congênita
Resumo
Justiﬁcativa  e  objetivo:  em  crianc¸as  submetidas  à  cirurgia  cardíaca  congênita,  os  níveis  plas-
máticos de  peptídeo  natriurético  cerebral  (PNC)  podem  ter  um  papel  no  desenvolvimento  da
síndrome  de  baixo  débito  cardíaco  (SBDC),  deﬁnida  como  uma  combinac¸ão  de  achados  clínicos
e  intervenc¸ões  para  aumentar  o  débito  cardíaco  em  crianc¸as  com  hipertensão  pulmonar.
Métodos: em  um  estudo  prospectivo  observacional,  foram  inscritas  51  crianc¸as  submetidas
à cirurgia  cardíaca  congênita,  com  avaliac¸ão  ecocardiográﬁca  pré-operatória  que  mostrava
hipertensão  pulmonar.  Os  níveis  plasmáticos  de  PNC  foram  avaliados  antes  e  12,  24  e  48  h  após
a  operac¸ão.  Os  pacientes  incluídos  no  estudo  foram  divididos  em  dois  grupos  em  func¸ão  de:  (1)
desenvolvimento  de  SBDC;  (2)  determinac¸ão  dos  valores  de  corte  de  PNC  no  pré-operatório  pela
análise  da  curva  de  funcionamento  do  receptor  para  SBDC.  Os  desfechos  secundários  foram:  (1)
durac¸ão  da  ventilac¸ão  mecânica  ≥  72  h,  (2)  permanência  em  unidade  de  terapia  intensiva  >  7
dias  e  (3)  mortalidade.
Resultados:  os  níveis  de  PNC  nos  períodos  pré-  e  pós-operatório  dos  pacientes  com  ou  sem
SBDC (n  =  35,  n  =  16,  respectivamente)  apresentaram  diferenc¸as  signiﬁcantes  nos  tempos  de
mensurac¸ão  repetidos  (p  =  0,0001).  O  valor  de  corte  de  PNC  de  125,5  pg  mL−1 no  pré-operatório
obteve a  maior  sensibilidade  de  88,9%  e  especiﬁcidade  de  96,9%  para  prever  a  SBDC  em
pacientes  com  hipertensão  pulmonar.  Uma  boa  correlac¸ão  foi  descoberta  entre  o  nível  plas-
mático  de  PNC  no  pré-operatório  e  durac¸ão  a  ventilac¸ão  mecânica  (r  =  0,67,  p  =  0,0001).
Conclusões:  em  pacientes  com  hipertensão  pulmonar  submetidos  à  cirurgia  cardíaca  congênita,
91% com  níveis  plasmáticos  de  PNC  acima  de  125,5  pg  mL−1 no  período  pré-operatório  estão  em
risco  de  desenvolver  a  SBDC,  que  é  um  desfecho  importante  no  pós-operatório.
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Introduction
Plasma  brain  natriuretic  peptide  (BNP)  is  a  neurohormone
that is  secreted  mainly  by  the  ventricles  in  response  to
an increase  in  right  or  left  ventricular  pressures  as  well
as volume  overload.  This  neurohormone  has  natriuretic,
diuretic and  vasodilatory  properties.1,2 Right  ventricular
(RV) dysfunction  refers  to  abnormalities  of  ﬁlling  or  contrac-
tion without  reference  to  signs  or  symptoms  of  heart
failure. Pulmonary  hypertension  (PH)  is  deﬁned  as;  an
echocardiographic ﬁnding  of  a  mean  pulmonary  artery  pres-
sure ≥25  mm  Hg  at  rest  and  heart  failure  (HF)  is  deﬁned
as; left  ventricular  pump  dysfunction  causing  dilation,
thinned walls,  and  poor  contractility  of  the  heart  are
important causes  of  RV  dysfunction.1,3 The  use  of  brain
natriuretic peptide  (BNP)  as  an  indicator  of  RV  dysfunction
in children  with  PH  undergoing  congenital  heart  surgeries
remains largely  unknown.  Previous  studies  demonstrated  an
increase in  BNP  levels  preoperatively  and  postoperatively
in patients  with  ventricular  septal  defect  or  ventricular
3--6dysfunction. In  recent  studies,  the  goal  was  to  investigate
whether BNP  levels  can  be  used  as  a  tool  in  determi-
nation of  diagnosis  and  prognosis  of  children.6--9 It  was
reported that  plasma  BNP  levels  increased  immediately
p
a
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fter  congenital  heart  surgeries  despite  hemodynamic
nloading and  also  a  correlation  between  peak  BNP  level
o cardiopulmonary  bypass  (CPB)  time  was  demonstrated.10
he  development  of  low  cardiac  output  state  (LCOS)  has
ecently been  used  as  a  postoperative  outcome  measure  in
atients undergoing  congenital  cardiac  surgery.11,12 LCOS  is
eﬁned as:  tachycardia,  poor  peripheral  perfusion,  oliguria,
ardiac arrest,  need  for  a  100%  increase  in  pharmacolog-
cal support  or  administration  of  a  new  inotropic  agent,
etabolic acidosis  with  an  increase  in  base  deﬁcit.13,14
here  are  only  a  few  studies  providing  data  that  plasma
NP levels  may  help  to  identify  children  with  PH  caus-
ng RV  dysfunction. 6,11,12 Also,  it  was  demonstrated  that
n children  with  moderately  symptomatic  HF,  BNP  level
reater than  or  equal  to  140  pg  mL−1 and  age  greater
han 2  years  are  independently  associated  with  poorer
utcomes.15
Our  goal  was  to  investigate  a  relation  between  plasma
NP levels  and  postoperative  clinical  outcomes  such  as
COS, duration  of  mechanical  ventilation,  intensive  care
nit stay  and  mortality  in  a  30-day  postoperative  period  in
Este é um artigo Open Access sob a licença de CC BY-NC-NDatients undergoing  congenital  heart  surgeries  with  CPB.  In
ddition, we  compared  plasma  BNP  levels  before  and  after
urgery in  patients  with  or  without  LCOS.
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nitol at  a  dose  of  3  mL  kg−1.  Packed  red  blood  cells  were28  
ethods
atients
ifty-one  patients  with  a  diagnosis  of  PH  and  congenital
eart disease  were  enrolled  in  a  prospective  observa-
ional study  design.  This  study  was  conducted  after  local
thical Committee  approval  during  the  period  of  July
008--September 2009.  We  obtained  written  informed
onsent from  the  patients’  parents  or  guardians  before
nrollment in  the  study.  In  all  patients,  the  presence  of
H and  RV  dysfunction  was  shown  by  an  echochardiographic
tudy before  operation.  PH  is  deﬁned  as:  systolic  systemic
rterial pressures  of  at  least  35  mm  Hg  or  exceeding  50%
f the  systemic  mean  arterial  pressure  (MAP).12,15,16 The
etection of  PH  is  based  on  the  systolic  pulmonary  artery
ressure (PAp)  calculated  from  velocities  of  the  tricuspid
r pulmonary  valve  regurgitations  obtained  by  echocardio-
raphic Doppler  studies.16,17 During  this  measurement  the
ollowing diagnostic  criteria  were  used  in  this  study;  (1)  esti-
ated ratio  of  pulmonary  to  systemic  pressure  (Pp/Ps)  using
oppler echocardiography  >0.5,  (2)  Systolic  PAp  was  mea-
ured by  Doppler  analysis  of  tricuspid  regurgitant  velocity
oppler ﬂow  and  depending  on  previous  studies  on  children
 relationship  of  systolic  PAp  to  diastolic  and  mean  PAp  were
ade accordingly,17 (3)  signiﬁcant  tricuspid  regurgitation,
4) enlarged  or  hypertrophied  RV  without  evidence  of  pul-
onary stenosis,  and  (5)  intraventricular  septal  ﬂattening.
V dysfunction  is  diagnosed  based  on  the  echocardiographic
ata and  the  most  important  parameter  in  the  diagnosis
nclude: tricuspid  annular  plane  systolic  excursion  (TAPSE)
alue that  is  based  on  the  age  of  the  patient  to  assess  RV  sys-
olic function.16,17 The  echocardiographic  studies  were  done
y the  same  pediatric  cardiologist  preoperatively  and  post-
peratively every  12  h  and  if  there  are  clinical  signs  of  PH
risis.
All patients  had  one  of  the  congenital  heart  diseases
hat have  high  risk  for  developing  postoperative  pulmonary
ypertension and  these  include:  (1)  isolated  VSD,  (2)  Ven-
ricular septal  defect  (VSD)  and  total  anomalous  pulmonary
enous connection  (TAPVR),  (3)  Ventricular  septal  defect
VSD) and  partial  anomalous  pulmonary  venous  connec-
ion (PAPVR),  (4)  VSD  with  or  without  atrial  septal  defect
ASD) and/or  PAPVR,  and  (5)  atrioventricular  canal  defect
AVSD).18 Patients  with  single  ventricle  pathologies  were
ncluded into  the  study.  Patients  having  cardiomyopathies,
ransposition of  the  great  arteries,  truncus  arteriosus  and
ypoplastic left  heart  syndrome  were  not  included.  In  the
tudy group  all  patients  had  systolic  Pap  values  between
0 and  70  mm  Hg  with  systemic  MAP  values  between  50  and
0%. Patients  with  systolic  PAp  values  above  70  mm  Hg  with
 systemic  MAP  value  above  60%  were  excluded  from  the
tudy.
All of  the  patients  underwent  congenital  heart  repair
urgery with  CPB.  In  our  study  the  same  surgical  team
as involved  in  all  surgical  procedures.  The  patients  were
ivided into  two  groups  depending  on:  (1)  Development  of
COS postoperatively  and  (2)  preoperative  BNP  cut-off  value
as determined  by  receiver  operating  curve  (ROC)  analysis
or LCOS.11,13,14 Oliguria  is  deﬁned  as  a  urine  output  that  is
ess than  1  mL  kg−1 h−1 in  infants,  less  than  0.5  mL  kg−1 h−1
n  children.19 In  children,  the  normal  reference  values  for
u
o
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eart  rate  (HR)  and  systemic  mean  arterial  pressure  were
rovided in  previous  guidelines.20,21
rimary  and  secondary  end  points
he  primary  end  point  was  the  development  of  LCOS  within
0 days  of  surgery  which  is  an  adverse  postoperative  out-
ome. The  secondary  end  points  include  the  development  of
ther adverse  outcomes  within  30  days  of  surgery  and  these
nclude: (1)  Duration  of  mechanical  ventilation  longer  than
2 h  postoperatively,  (2)  Duration  of  intensive  care  unit  stay
onger  than  7  days,  (3)  Mortality  in  the  30-day  postoperative
eriod, and  (4)  Development  of  other  complications  such  as
eurologic deﬁcit,  pneumonia,  renal  failure,  ventricular  and
trial arrhythmias,  complete  atrioventricular  block.
ntraoperative  anesthetic  management
he  preoperative  anesthesia  management,  intraoperative
urgical strategy,  and  pediatric  intensive  care  unit  man-
gement protocols  are  explained  in  detail  previously.20
tandard  anesthetic  monitoring  include:  ﬁve-lead  electro-
ardiogram, pulse  oximeter,  rectal  temperature  probe,  end
idal carbon  dioxide,  arterial  catheter  and  central  venous
atheter. Intraoperative  transesophageal  echocardiography
as used  only  occasionally.  At  the  end  of  CPB,  RV  systolic
nd diastolic  pressures  were  measured  via  an  appropri-
te sized  arterial  catheter  inserted  to  the  right  ventricle.
he catheter  was  pulled  out  during  closure  of  the  ster-
um. RV  mean  pressure  was  collected  at  the  end  of  CPB.
hildren with  hemodynamic  instability  had  transthoracic  or
ransesophageal echocardiographic  studies  done  in  the  ICU;
owever, echocardiographic  evaluation  was  not  available
uring operation.  During  surgery,  general  anesthesia  was
nduced with  the  use  of  midazolam  at  a dose  of  200  g  kg−1,
entanyl sulfate  at  a  dose  of  25  g  kg−1,  and  pancuronium
romide at  a dose  of  0.1  mg  kg−1. Patients  received  repeated
oses of  fentanyl  at  a  dose  of  5  g  kg−1 and  midazolam  at  a
ose of  50  g  kg−1 every  half  an  hour  throughout  surgery  and
nhalational anesthetic  of  sevoﬂurane  at  a  dose  of  1.0--2.0
AC (minimum  alveolar  concentration)  was  also  provided
epending on  systemic  MAP.  Neonates  and  infants  were  intu-
ated with  uncuffed  endotracheal  tubes  and  intraoperative
nd postoperative  ventilation  was  maintained  with  volume-
r pressure-controlled  ventilation.  Perioperative  antibi-
tic prophylaxis  included  cefazolin.  Methyprednisolone  was
dministered to  all  patients  intravenously  in  two  equally
ivided doses  of  10  mg  kg−1 each  before  the  start  of  CPB.
ardiopulmonary  bypass  protocol
he  CPB  circuit  included  a  roller  pump,  a  disposable  mem-
rane oxygenator,  and  an  arterial  ﬁlter.  CPB  was  established
sing an  arterial  cannula  and  bicaval  or  a  single  two-stage
enous cannulae.  Cooling  and  rewarming  were  carried  out
ith a  heat  exchanger.  The  priming  solution  consisted  of
 crystalloid  solution  of  isotonic  sodium  chloride  and  man-sed to  obtain  a haematocrit  value  of  25%  before  start
f CPB.  Heparinization  was  achieved  with  heparin  sulfate.
uring CPB,  a  perfusion  index  of  2.4--2.6  L  min−1 m−1 was
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used.  Moderate  hypothermia  was  performed  at  28 ◦C.  After
cross-clamp placement,  blood  cardioplegia  with  addition  of
potassium chloride,  sodium  bicarbonate,  magnesium  sulfate
was given  at  the  dose  of  30  mL  kg−1.  Intermittent  antegrade
cold blood  cardioplegia  at  4 ◦C  was  used  for  myocardial  pro-
tection. Heparin  was  neutralized  with  protamine  sulfate  in
a 1:1.5  ratio.  Intravenous  administration  of  vasodilator  and
inotropic agents  were  used  if  necessary  to  wean  patients
from CPB.  Volume  substitution  was  carried  out  with  fresh
frozen plasma  or  5%  human  albumin.
Perioperative  and  postoperative  care
The  parameters  that  were  collected  during  surgery  and  in
the 24  h  postoperative  period  include:  demographic  data,
CPB, aortic  cross-clamp  time,  HR,  systemic  MAP,  mean  RV
pressure, central  venous  pressure  (CVP),  arterial  oxygen  sat-
uration, urine  output,  ﬂuid  balance,  inotrope  agents  and
doses. Parameters  were  recorded  every  30  min  throughout
the operative  procedure  and  every  30  min  in  the  intensive
care unit  after  operation.  Postoperative  adverse  outcome
related parameters  including  duration  of  mechanical  ven-
tilation, intensive  care  unit  (ICU)  stay,  hospital  stay  and
30-day mortality  were  collected.  Prolonged  mechanical  ven-
tilation is  described  as  mechanical  ventilation  (MV)  ≥72  h
following operation.22 Prolonged  ICU  stay  >7  days  is  consid-
ered as  an  adverse  event.23 The  patients  were  evaluated
for postoperative  adverse  events  every  12  h  by  the  research
team including  a  physician  and  resident.
Postoperative  PH  crisis  was  deﬁned  as  an  increase  in
systolic PAp  to  the  level  of  systemic  MAP  or  greater  and
is accompanied  by  a  fall  in  systemic  MAP,  a  fall  in  arte-
rial or  venous  oxygen  saturation,  or  both.  The  deﬁnition  is
also associated  with  hypoxemia,  development  of  metabolic
acidosis and/or  hypovolemia.  In  all  of  our  children  PAps
(systolic and  correlated  diastolic  and  mean  PAps)17 were  cal-
culated by  echocardiographic  Doppler  studies  in  the  ICU  as
described in  patients  section.  The  detection  of  postopera-
tive PH  was  based  on  clinical  signs  and  echocardiographic
studies in  the  ICU.16,17 The  important  treatment  measures  to
avoid an  increase  of  PAps  intraoperatively  and  in  the  post-
operative period  in  ICU  include:  (1)  To  support  oxygenation
with inspiratory  FiO2 at  a  level  of  0.6--1.0;  (2)  To  provide
moderate hyperventilation  (to  keep  PaCO2 level  between  30
and 35  mm  Hg);  (3)  To  avoid  development  of  metabolic  acid-
osis (to  keep  pH  above  7.4);  (4)  To  provide  a  recruitment
maneuver to  avoid  ventilation/perfusion  mismatch;  (5)  To
provide a  low-tidal-volume  ventilation  to  avoid  overinﬂa-
tion of  aveoli  (to  keep  tidal  volume  between  6  and  8  mL  kg−1
ideal  body  weight);  (6)  To  provide  a  temperature  manage-
ment to  maintain  body  temperature  of  36--37 ◦C  at  the  end
of CPB  and  (7)  To  provide  a  ‘‘goal-directed’’  ﬂuid  and  volume
therapy the  effectiveness  of  hemodinamical  monitoring  was
followed by  measurements  of  necessary  parameters  which
include; HR,  systemic  MAP,  mean  RV  pressure,  central  venous
pressure (CVP),  arterial  oxygen  saturation,  urine  output  and
ﬂuid balance.24,25
Children  at  risk  for  or  with  signs  of  postoperative
PH were  sedated,  received  mechanical  ventilatory  sup-
port, and  usually  received  inotropic  support  (dobutamine
and/or dopamine,  additional  inotropes  of  adrenaline  and/or
noradrenaline). Intravenous  nitroglycerin  at  a  dose  of
c
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.5--3  g  kg−1 min−1 was  provided  to  patients  by  appropriate
ollow-up of  the  hemodynamical  parameters.  These  agents
re administered  through  a right  central  venous  line  in
n attempt  to  keep  PAps  less  than  40%  of  systemic  MAP.
he administration  of  nitroglycerin  is  recommended  for
ntravenous vasodilation.  As  the  effect  of  this  medication
s not  limited  to  the  pulmonary  circulation  and  therefore
lso induces  systemic  vasodilation,  its  administration  often
auses a  considerable  decrease  in  systemic  MAP  and  involves
he risk  of  right-ventricular  perfusion  pressure  falling  below
 critical  limit.16,24,25 In  the  acutely  decompensated  PH,
nhaled nitric  oxide,  intravenous  or  inhaled  epoprostenol,
loprost, and  inotropic  support  are  the  most  useful  agents.18
owever,  in  our  study  routine  use  of  these  agents  was  not
vailable.
PH related  events  were  treated  with  manual  hyperven-
ilation with  100%  oxygen  and  intravenous  use  of  opiate;
entanyl at  a  dose  of  5--10  g  kg−1.  For  patients  with  PH,
echanical ventilation  was  continued  until  the  echocar-
iographic studies  showed  well-controlled  measurements  of
Aps as  well  as  an  improvement  in  clinical  status  indicating
hat myocardial  function  had  recovered.  After  extubation
nd when  there  was  no  longer  any  need  for  invasive  moni-
oring or  vasoactive  drugs,  the  child  was  transferred  to  the
ard.16,24,25
erioperative  measurements
lasma  levels  of  BNP  and  arterial  blood  gases  were  col-
ected preoperatively,  12,  24  and  48  h  postoperatively  from
lood samples  of  an  arterial  catheter  that  was  inserted
t the  beginning  of  the  surgery  before  induction  of  anes-
hesia. The  surgical  and  medical  teams  that  are  involved
n the  management  of  the  study  patients  were  blinded  to
lasma BNP  values.  The  plasma  levels  of  BNP  were  measured
sing a  commercially  available  ﬂuorescence  immunoassay
Triage, Beckman  Coulter,  Inc.  San  Diego,  California,  USA).
he measurable  range  of  BNP  on  this  device  is  between  5
nd 5000  pg  mL−1.
tatistical  analysis
tatistical  analyses  were  performed  using  SPSS  17.0.1  for
indows software  (SPSS  Software,  Chicago,  IL,  USA).  In  the
tudy by  Hsu  et  al.  a  sample  size  of  32  including  16  patients
n each  group  with  or  without  LCOS  is  needed  to  detect  a
ifference of  prolonged  intensive  care  unit  stay  of  1  day
1 standard  deviation)  using  2-sided  signiﬁcance,  a  power
1 −  ß)  of  80%  and  an  ˛  =  0.05.11 All  variables  were  tested
or normal  distribution  using  the  Kolmogorov--Smirnov  test.
ifferences of  categorical  variables  were  tested  with  chi
quare test.  Differences  of  continuous  variables  that  are
ot normally  distributed  were  tested  with  Mann--Whitney
 test.  Changes  in  plasma  BNP  levels  were  compared  using
epeated-measures analyses  of  variance  (ANOVA).  The  utility
f preoperative  BNP  as  a  prognostic  indicator  of  postop-
rative outcome  was  evaluated  using  receiver  operating
haracteristic (ROC)  curves  and  the  areas  under  curve
AUC) as  well  as  sensitivity  and  speciﬁcity  were  calculated.
ifferences with  a  p-value  below  0.05  were  considered  sta-
istically signiﬁcant.
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Figure  1  ROC  (receiver  operating  curve)  for  preoperative
plasma BNP  values.  A  cut-off  value  of  125.5  pg  mL−1 has  a  sen-
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atient  data
ifty-one  patients  were  included  into  the  study  group.  Age,
eight, gender,  and  the  type  of  cardiac  lesions  are  shown  in
able 1.  The  median  age  of  the  study  group  of  51  patients
as 1.10  years  (range  0.3--3.0  years).  The  median  weight
as 7.00  kg  (range  4.00--26.00).  In  this  group,  there  were  23
45.1%) male  and  28  (54.9%)  female  patients.  In  the  whole
roup, there  were  5  patients  (9.8%)  with  isolated  VSD,  2
3.9%) patients  with  VSD  with  TAPVR,  13  (25.5%)  patients
ith VSD  and  PAPVR  (w/wo  ASD),  15  (29.4%)  patients  had
SD with  ASD  and  16  (31.4%)  patients  had  AVSD.  Six  patients
ad trisomy  21.  In  the  whole  group  of  patients,  thirty-seven
atients (72.5%)  showed  one  or  more  of  the  signs  of  HF  and
hese include:  failure  to  thrive,  respiratory  distress,  or  hepa-
omegaly  and  all  of  them  had  one  or  more  of  the  following
edications: digitalis,  diuretic  and  angiotensin  converting
nzyme inhibitor.
The distribution  of  baseline  characteristics  of  patients
fter determination  of  preoperative  BNP  cut-off  value  by
eceiver operating  curve  (ROC)  analysis  for  LCOS  is  pre-
ented in  Table  1.  The  preoperative  BNP  cut-off  value  of
25.5 pg  mL−1 was  found  to  have  the  highest  sensitivity  of
8.9% and  speciﬁcity  of  96.9%  in  predicting  LCOS  in  patients
ith PH  and  the  area  under  curve  (AUC)  is  91%  (Fig.  1).
his ﬁnding  shows  that  91%  of  patients  with  a  preoperative
lasma BNP  level  above  125.5  pg  mL−1 value  is  at  very  high
isk of  developing  LCOS.  Perioperative  BNP  levels  in  both
roups are  shown  in  Table  2.  There  were  signiﬁcant  differ-
nces in  the  comparison  of  plasma  BNP  levels  of  patients
n repeated  measure  time  points  with  or  without  LCOS
p = 0.0001).
w
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Table  1  The  distribution  of  baseline  characteristics  of  patient
receiver  operating  curve  (ROC)  analysis  for  LCOS.
Patients  LCOS  (−)  LCOS  (+)  
n  =  35  n  =  16  
Age  (year)  2.00  0.95  
(median,  range)a (0.3--3.0)  (0.4--3.0)  
Weight  (kg)  10.0  5.25  
(median,  range)a (4.0--26.0)  (4.0--26.0)  
Male/female,  n  (%)a 18  (35.3)/17  (33.3)  5  (9.8)/11  (21.6)  
a p < 0.05 statistically signiﬁcant, median (range; minimum and maxi
n  (%), number (percentage); LCOS, low cardiac output syndrome; preB
Table  2  The  comparison  of  changes  in  plasma  BNP  levels  over  tim
Preoperative
BNP
Postoperative
12-h  BNP
All  patients  (n  =  51)  138.6  ±  109.6  482.9  ±  501.8
LCOS  (−)  (n  =  35)  88.9  ±  60.9  264.2  ±  184.5
LCOS  (+)  (n  =  16)  247.1  ±  115.5  961.3  ±  637.8
pa 0.0001  0.0001  
a p < 0.05 statistically signiﬁcant; analysis was performed using repeate
test; BNP, plasma brain natriuretic peptide (pg mL−1).itivity of  88.9%,  a  speciﬁcity  of  96.9%  and  area  under  curve
AUC) of  91%  for  predicting  low  cardiac  output  state  (LCOS).
Five  infants  with  PH  died  within  30  days  after  operation
n = 5/51,  9.8%).  Two  of  the  deaths  occurred  within  two  days
fter correction.  The  two  infants,  a  30-month-old,  11-kg  girl
ith history  of  Down  syndrome  and  AVSD  and  a  14-month-
ld, 9-kg  boy  with  VSD  and  TAPVR  were  detected  to  show
ncreased mean  RV  pressure  and  severe  right  to  left  shunting
ith a  transcutaneous  oxygen  saturation  of  45--84%  during
urgery. At  the  end  of  the  correction,  both  infants  required
notropic support  of  dopamine,  dobutamine,  adrenaline  and
oradrenaline in  addition  to  vasodilator  therapy  of  iloprost
s  after  determination  of  preoperative  BNP  cut-off  value  by
pa preBNP  ≤  125  preBNP  >  125  pa
n  =  30  n  =  21
0.072  2.00  0.80  0.009
(0.3--3.0)  (0.4--3.0)
0.017  10.3  5.5  0.024
(4.0--26.0)  (4.0--26.0)
0.179  15  (50)/15  (50)  13  (61.9)/8  (38.1)  0.290
mum) values were provided for not normally distributed data.
NP, preoperative plasma brain natriuretic peptide (pg mL−1).
e  before  and  after  surgery.
Postoperative
24-h  BNP
Postoperative
48-h  BNP
pa
 850.2  ±  1186.9  914.6  ±  1199.3  0.0001
 337.1  ±  232.5  289.3  ±  222.7  0.0001
 1972.4  ±  1617.5  1331.9  ±  2222.5  0.0001
0.0001  0.0001
d measures analysis of variance (ANOVA) and Greenhouse--Geisser
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Table  3  The  parameters  signiﬁcant  for  outcome  in  the  30-day  early  postoperative  period.
Patients  LCOS  (−)  (n  =  35)  LCOS  (+)  (n  =  16)  pa preBNP  ≤  125  (n  =  30)  preBNP  >  125  (n  =  21)  pa
CPBa time,  (min)b 92.0  (30.0--120.0)  102.0  (65.0--217.0)  0.003  41.5  (10.0--93.0)  56.0  (15.0--217.0)  0.128
Aortic  cross  clamp
time, (min)b
41.0  (10.0--77.0)  48.0  (20.0--126.0)  0.431  91.0  (40.0--120.0)  97.0  (30.0--126.0)  0.066
Duration  of
mechanical
ventilation,
(day)b
2.0  (1.0--5.0)  5.0  (2.0--32.0)  0.0001  2.0  (1.0--4.0)  4.0  (1.0--32.0)  0.0001
Intensive  care  unit
stay, (day)b
4.0  (2.0--10.0) 9.0  (2.0--32.0) 0.008 4.0  (2.0--15.0) 8.0  (2.0--32.0)  0.026
Development  of
LCOS, n(%)
0 (0)  16  (100)  0.0001  2(6.7)  14  (66.7)  0.0001
30-day  mortality,
n(%)
0 (0)  5  (31.3)  0.0001  0(0)  5  (23.8)  0.0001
a p < 0.05 statistically signiﬁcant; data are presented as mean ± standard deviation or n: number, percentage.
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3Median (minimum and maximum) values were provided for n
(pg mL−1); CPB, cardiopulmonary bypass; LCOS, low cardiac outpu
and  nitroglycerine;  however,  cardiac  arrest  was  unpre-
ventable within  36--48  h  after  surgery.  In  both  cases,  PH
and tricuspid  insufﬁciency  were  observed  by  the  echocar-
diographic Doppler  studies  that  were  performed  within  12  h
after surgery.  The  third  patient  was  a  boy  at  age  of  12
months and  weight  of  8  kg.  He  had  a  diagnosis  of  VSD  and
PAPVR and  this  patient  survived  ﬁve  days  in  the  ICU  before
cardiac arrest  secondary  to  a  PH  crisis  which  was  diag-
nosed with  clinical  ﬁndings.  The  two  other  patients  had
both ASD  and  VSD  as  well  as  severe  PH  before  surgery.
One of  them  was  a  4-month-old,  5-kg  boy  and  the  other
was a  3-month-old,  4-kg  girl  with  a  diagnosis  of  Down  syn-
drome. The  male  patient  survived  for  only  three  days  in
ICU before  cardiac  arrest  secondary  PH  crisis  whereas  the
female patient  had  symptoms  of  LCOS  within  12  h  after
surgery requiring  peritoneal  dialysis  and  inotropic  support.
Despite adequate  therapy,  she  survived  13  days  in  the  ICU
before cardiac  arrest  secondary  to  LCOS.  Inhalation  of  nitric
oxide was  provided  to  only  six  patients  with  signs  of  severe
PH in  ICU.
o
b
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Table  4  Division  of  intraoperative  and  postoperative  characteris
Parameters  Group  LCOS  (
Intraoperative  hemodynamical  data  (at  the  end  of  CPB)
Heart  rate  (/min)  159.42  ±  9.2
Mean  systemic  arterial  pressure  (mm  Hg) 81.91 ±  14.
Mean  right  ventricular  pressure  (mm  Hg) 39.89 ±  5.6
Arterial  oxygen  saturation  (%)  98.04  ±  2.5
Central  venous  pressure  (mm  Hg)  10.26  ±  2.1
Postoperative  12  h  hemodynamic  data
Heart rate  (min)  165.42  ±  7.8
Mean  systemic  arterial  pressure  (mm  Hg)  79.94  ±  13.
Arterial  oxygen  saturation  (%)  95.75  ±  3.8
Central  venous  pressure  (mm  Hg)  10.14  ±  2.4
a p < 0.05 statistically signiﬁcant; data are presented as mean ± stan
bypass; LCOS, Low cardiac output state.rmally distributed data. BNP, plasma brain natriuretic peptide
te.
utcome  measures
he  LCOS  (−)  group  had  no  deaths  and  better  outcome  in
he 30-day  postoperative  period  after  surgery  whereas  in
COS (+)  group  5  of  the  16  patients  (31.25%)  died  in  the
arly postoperative  period.  Four  patients  died  within  7  days
eriod whereas  one  patient  survived  for  12  days  postopera-
ively. The  data  on  postoperative  outcomes  as  well  as  30-day
ortality are  provided  in  Table  3.
The  differences  between  systemic  MAPs,  mean  RV
ressures and  CVPs  during  surgery  and  on  postoperative
2 h  are  shown  in  Table  4.  Systemic  MAPs  were  not  signif-
cantly different  between  LCOS  (−)  and  LCOS  (+)  groups  at
he end  of  CPB.  However,  at  this  time  point,  the  patients
ith LCOS  showed  higher  RV  pressures  of  43.50  ±  5.96  mm  Hg
n  comparison  to  the  other  patients  showing  a  value  of
8.89 ±  5.03  mm  Hg  (p  =  0.005).  The  comparison  of  arterial
xygen saturation  and  CVP  showed  no  signiﬁcant  differences
etween groups  (98.04  ±  2.56%  vs.  96.01  ±  9.24%,  p  =  0.191
nd 10.26  ±  2.15  mm  Hg  vs.  10.19  ±  2.29  mm  Hg,  p  =  0.385,
tics  of  patients  depending  on  low  cardiac  output  state.
−)  (n  =  35)  Group  LCOS  (+)  (n  =  16)  pa
5  156.30  ±  8.82  0.213
08  77.44  ±  11.44  0.359
3 43.50 ±  5.96  0.005
6  96.01  ±  9.24  0.191
5  10.19  ±  2.29  0.385
1  166.42  ±  8.43  0.581
16  81.44  ±  10.98  0.329
0  86.06  ±  7.57  0.0001
3  16.19  ±  3.26  0.0001
dard deviation or n: number, percentage; CPB, Cardiopulmonary
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espectively).  On  postoperative  12  h,  while  there  was  no
ifference in  comparison  of  systemic  MAPs  between  LCOS
−) and  LCOS  (+)  groups,  patients  with  LCOS  showed  higher
Vps and  lower  arterial  oxygen  saturations  in  comparison  to
he patients  without  LCOS  (95.75  ±  3.80%  vs.  86.06  ±  7.57%,
 =  0.0001  and  10.14  ±  2.43  mm  Hg  vs.  16.19  ±  3.26  mm  Hg
 =  0.0001,  respectively)  (Table  4).
A good  correlation  was  found  between  preoperative
lasma BNP  level  and  duration  of  mechanical  ventila-
ion (r  =  0.67,  p  =  0.0001);  however,  weak  correlations  were
resent between  preoperative  plasma  BNP  level  and  aortic
ross clamp  time  (rho  =  0.431,  p  =  0.002),  intensive  care  unit
tay (r  =  0.42,  p  =  0.002)  and  mortality  (r  =  0.47,  p  =  0.001).
iscussion
he  major  ﬁndings  of  this  study  include:  (1)  In  comparison  to
reoperative plasma  BNP  levels,  postoperative  values  show
igniﬁcant increase  in  repeated  measurement  time  points
f 12,  24  and  48  h  after  surgery  in  patients  with  or  with-
ut development  of  LCOS  in  the  postoperative  period.  (2)
n patients  with  PH  undergoing  congenital  heart  surgery,
1% of  patients  with  preoperative  plasma  BNP  levels  above
25.5 pg  mL−1 are  at  high  risk  of  developing  LCOS  which  is  an
mportant risk  factor  for  determination  of  early  30-day  post-
perative outcome.  (3)  The  preoperative  plasma  BNP  level
ccurately predicts  postoperative  LCOS  in  children  with  PH
nd these  ﬁndings  have  not  been  reported  previously  in  stud-
es investigating  pulmonary  hypertension  in  children.16,24--27
4)  Secondary  outcome  measures  in  the  early  postoperative
eriod such  as  duration  of  mechanical  ventilation  and  inten-
ive care  unit  stay  were  prolonged  in  patients  with  LCOS  in
omparison to  patients  without  LCOS  (p  =  0.0001,  p  =  0.008,
espectively).
In the  study  by  Hoffmann  et  al.,  238  patients  were  divided
nto three  groups  as:  placebo,  low-dose  milrinone,  and  high-
ose  milrinone  groups  and  LCOS  rates  were  25.9%,  17.5%,
nd 11.7%  respectively  in  the  ﬁrst  36  h  after  congenital  heart
urgery. LCOS  patients  had  a  signiﬁcantly  longer  duration
f mechanical  ventilation  (3.1  vs.  1.4  days,  p  =  0.001)  and
ospital stay  (11.3  vs.  8.9  days,  p  =  0.016)  in  comparison  to
atients without  LCOS.13
In  children  with  congenital  heart  disease  who  present
ith signiﬁcant  PH  and  predominant  left-to-right  shunt,  a
atio of  pulmonary  to  systemic  resistance  ≤2/3  is  used  as
 threshold  associated  with  better  surgical  outcomes.18 The
auses of  signs  of  development  of  RV  failure  at  the  opera-
ion may  be  related  to:  (1)  different  initial  volume  status,
2) varying  baseline  end-diastolic  volumes,  or  (3)  varying
egrees of  ischemic  burden  and  injury  and  for  treatment
f this  pathophysiological  ﬁnding  an  initial  ﬂuid  challenge
f normal  saline  followed  by  diuresis  is  required.17,24 In  the
tudy by  Bando  et  al.  children  with  AV  canal,  truncus  arterio-
us, TAPVR,  transposition  of  the  great  arteries,  hypoplastic
eft heart  syndrome,  and  VSD  were  determined  to  be  at
igh risk  for  the  development  of  postoperative  pulmonary
ypertensive events.25 In  this  study  880  patients  at  high  risk
f developing  postoperative  pulmonary  events  were  eval-
ated and  the  number  of  pulmonary  hypertensive  events
ere recorded  in  138  (16%)  of  the  patients  and  the  mortal-
ty in  this  patient  population  was  75  (8.5%).  The  data  show
b
t
p
(A.  Baysal  et  al.
hat  the  mortality  rates  in  children  with  a  diagnosis  of  PH
ndergoing congenital  heart  repair  surgery  is  signiﬁcantly
igher than  patients  without  PH.  Furthermore,  the  number
f early  deaths  associated  with  PH  event  was  31  (22.5%)  in
38 patients.  Regarding  patients  with  severe  PH  crisis,  the
tudy by  Bando  et  al.  found  a  mortality  of  35.5%  (n  =  11/31)
n 1990  through  1994  whereas  in  recent  studies  it  is  also
oted that  one  complication  in  addition  to  simple  correction
f congenital  heart  disease  is  associated  with  a  mortality
ate up  to  9.0%.26 Lindberg  et  al.  reported  a  mortality  rate
f 7.4%  (n  =  2/27).24 The  mortality  rate  in  our  study  group
s 9.8%  and  this  primary  outcome  result  is  compatible  with
revious reports.24--27
Our  patients  presented  later  to  the  clinic  at  sicker  health
tatus in  comparison  to  the  reported  case  series  in  the  liter-
ture. In  our  study  group  the  median  age  of  12  months  was
igher than  the  median  age  (4.2--8.6  months)  of  the  reported
tudies showing  that  early  diagnoses  and  treatment  was  not
lways  possible  in  our  group  of  patients.24,27 In  our  study,
he patients  with  LCOS  had  lower  mean  body  weights  and
he incidence  of  preterm  birth  history  in  this  group  was  9
ut of  16  patients  (56.3%)  whereas  patients  without  LCOS
ad higher  mean  body  weight  with  an  incidence  of  preterm
irth history  was  4  out  of  35  (11.4%)  (Table  2).  Our  ﬁnd-
ngs support  the  data  provided  by  the  literature  that  failure
o thrive  is  a  signiﬁcant  ﬁnding  in  congenital  heart  diseases
ith PH.3 Remarkably,  outcome  of  preterm  infants  with  CHD
as signiﬁcantly  worse  than  that  for  full-term  infants.27
An  increased  PVR  and  PAP  and  RV  failure  may  have
layed an  important  role  in  the  cause  of  deaths  of  our
atients. In  prevention  of  PH  crisis  in  the  early  postop-
rative period  inhaled  nitric  oxide,  intravenous  or  inhaled
poprostenol, iloprost,  and  inotropic  support  are  the
ost useful  agents  and  newer  emerging  methods  include:
xtracorporeal membrane  oxygenation  and  continuous  mon-
toring of  mixed  venous  saturation  (SvO2)  through  pulmonary
rtery catheter.16,18,24 We  were  not  able  to  perform  pul-
onary artery  catheterization  in  all  of  our  patients  and
nclusion of  the  data  of  these  measurements  was  not  pos-
ible in  our  study  although  our  observations  support  that
ulmonary artery  catheterization  is  beneﬁcial  in  detec-
ing pulmonary  hypertensive  events  in  the  early  period.  It
as been  reported  that  PAps  and  CVPs  gradually  increase
nd SvO2 decreases  before  severe  pulmonary  hypertensive
rises occur.24,25,28 Hypoxemia,  hypercapnia,  metabolic  acid-
sis, restlessness,  and  tracheal  suctioning  may  increase
ulmonary vasoreactivity  and  thus  trigger  postoperative  pul-
onary hypertensive  events.  For  prevention  of  these  events,
oderate hyperventilation  with  a  high  inspired  oxygen  frac-
ion, sedation,  and  paralysis  have  been  used  in  our  study.
nhaled nitric  oxide  was  available  in  only  six  patients  who
ad severe  PH  crisis  in  the  ICU  in  our  study  group.
A  decision  for  a  cutoff  value  for  BNP  levels  was  unable
o be  established  even  for  noncomplex  lesions.  In  a  study
y Koch  and  his  colleagues,  65  patients  were  evaluated  as  a
ingle group  of  patients  undergoing  congenital  heart  surgery
nd afterwards  a  division  into  two  groups  depending  on  their
omplexity of  their  cardiac  lesion  was  made.  The  difference
etween the  preoperative  BNP  and  postoperative  BNP  on
he ﬁrst  day  was  signiﬁcantly  greater  in  patients  with  com-
lex heart  defects  than  in  patients  with  more  simple  defects
median 213  pg  mL−1 vs.  453  pg  mL−1,  p  =  0.03).  In  their
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study,  postoperative  BNP  levels  were  signiﬁcantly  higher  in
patients with  univentricular  hearts  (median  1300  pg  mL−1).10
Oosterhof  and  his  coworkers  showed  that  in  univentricular
heart morphologies  with  systemic  right  ventricular  dys-
functions, preoperative  BNP  levels  greater  than  45  pg  mL−1
detect  right  ventricular  insufﬁciencies  with  a  sensitivity  of
78% and  a  speciﬁcity  of  84%.29 Mainly,  these  two  studies
provide data  for  need  of  further  investigation  of  pre-
operative plasma  BNP  levels  in  children  with  pulmonary
hypertension undergoing  congenital  heart  surgery  and  our
study provides  valuable  data  that  a  preoperative  plasma  BNP
level greater  than  125.5  pg  mL−1 detects  LCOS  which  is  an
important prognostic  risk  factor  in  the  early  30-day  postop-
erative period  with  a  sensitivity  of  88.9  and  a  speciﬁcity  of
96.9%. LCOS  has  been  used  as  a  tool  to  determine  outcome
after congenital  heart  surgeries.11,29 An  important  ﬁnding
is that  the  patients  with  LCOS  showed  signiﬁcantly  higher
preoperative BNP  values  in  patients  undergoing  congenital
heart surgery  with  CPB.  Our  observation  is  similar  to  a  recent
study by  Hsu  and  his  colleagues  that:  (1)  LCOS  is  associ-
ated with  poor  postoperative  outcome,  (2)  LCOS  actually
develops before  48  h  after  operation,  (3)  Postoperative  BNP
levels do  not  predict  LCOS;  however,  these  values  are  associ-
ated with  LCOS.11 A  preoperative  BNP  value  or  postoperative
2, 4,  12  or  24  h  BNP  values  were  reported  as  independent
biomarkers of  postoperative  outcome  related  risk  factors
such as  ICU  stay  or  prolonged  mechanical  ventilation.24,27--30
A  correlation  between  plasma  BNP  levels  and  duration
of mechanical  ventilation  was  shown  in  previous  studies
by Hsu  and  Shih  et  al.12,31 The  study  by  Hsu  and  his  co-
workers was  mainly  on  neonates  undergoing  Norwood  or
two-ventricle corrective  repair  and  it  supports  the  valuable
role of  BNP  in  predicting  poor  postoperative  outcome  after
congenital surgery  with  CPB  especially  in  the  24  h  period
after operation.31 In  a  recent  study  Shih  and  his  colleagues
showed that  12-h  B-type  natriuretic  peptide  levels  were
associated with  the  duration  of  mechanical  ventilation  and
the presence  of  a  LCOS  after  surgical  intervention.  In  their
study, the  cut-off  value  of  12  h  B-type  natriuretic  peptide
level greater  than  540  pg  mL−1 predicted  mechanical  venti-
lation beyond  48  h  with  a  sensitivity  of  88.9%  and  a  speciﬁcity
of 82.5%.12 In  our  patient  population,  a  good  correlation  was
found between  preoperative  plasma  BNP  level  and  duration
of mechanical  ventilation  (r  =  0.67,  p  =  0.0001)  which  is  sim-
ilar to  the  ﬁndings  of  Shih  et  al.  We  think  the  study  needs  to
be performed  on  larger  group  of  patients  to  demonstrate  the
importance of  plasma  BNP  values  in  patients  with  a  diagnosis
of PH  undergoing  congenital  heart  surgeries.
There  are  several  limitations  of  the  present  study.  One
important limitation  is  the  selection  of  patients  into  the
study group.  We  used  general  echocardiographic  diagnos-
tic criteria  for  measurement  of  PAps  instead  of  cardiac
catheterization. However,  we  think  the  whole  group  of
patients represents  a  single  group  as  we  evaluated  systolic
PAps with  systemic  MAPs.  Our  patients  presented  at  an  older
age after  a  period  of  inadequate  medical  treatment  causing
deterioration of  clinical  status.  In  our  study  group  we  had
eleven patients  (11/51,  21.6%)  with  preterm  birth  history
and it  has  been  reported  that  preterm  babies  show  poorer
postoperative outcomes.3,27 We  did  not  have  a  transtho-
racic echocardiography  in  our  clinic  and  pulmonary  artery
catheterization was  not  performed  in  these  sicker  children.333
uring  completion  of  this  study  inhaled  nitric  oxide  was  not
vailable  to  all  patients  and  other  newer  agents  such  as
ntravenous or  inhaled  epoprostenol,  iloprost  were  not  used
o prevent  PH  crisis  during  or  after  surgery.
In  conclusion,  the  preoperative  plasma  BNP  level  accu-
ately predicts  postoperative  LCOS  which  is  an  important
rognostic risk  factor  for  determination  of  early  30-day  post-
perative outcome  and  91%  of  patients  with  preoperative
lasma BNP  levels  above  125.5  pg  mL−1 are  at  high  risk  of
eveloping LCOS  in  children  undergoing  congenital  heart
urgery with  CPB.
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